Past Publications



Metabolomics biomarker discovery in cerebrospinal fluid for cerebral amyloid angiopathy. Van den Berg E, Kuiperij HB, Van Nostrand WE*, Peters TMA, Coene KLM, Engelke UFH, De Boer S, Verbeek MM. Alzheimer’s & Dementia, December 2020. Wiley.

A recommended “minimum data set” framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer’s Study (ARIAS). Alber J* et al. Alzheimer’s & Dementia, November 2020. Wiley.

Copper stabilizes antiparallel Beta-sheet fibrils of Ab40-Iowa in vascular amyloid. Crooks E, Ziliox M, Kawakami T, Victor T, Xu F*, Hojo H, Chiu K, Simmerling C, Van Nostrand WE*, Smith SO, and Miller L. Journal of Biological Chemistry, May 2020.

Estimation of self-sustained activity from persistent inward currents using firing rate profiles of multiple motor units in humans. Afsharipour B, Manzur N, Duchcherer J, Fenrich KF, Thompson CK, Negro F, Quinlan KA*, Bennett DJ, and Gorassini MA. Journal of Neurophysiology, May 2020.

Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS/FTD. Fallini C*, Khalil B, Smith CL, Rossoll W. Neurobiology of Disease, March 2020. PubMed.

Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy. Zhu X*, Hatfield J*, Sullivan JK*, Xu F*, Van Nostrand WE*. Journal of Neuroinflammation, March 2020. PubMed.

Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1. Popescu D*, Van Nostrand WE*, Robinson J*. International Journal of Molecular Science. March 2020. PubMed.

Altered Motoneuron Properties Contribute to Motor Deficits in a Rabbit Hypoxia-Ischemia Model of Cerebral Palsy. Steele PR*, Cavarsan CF*, Dowaliby L*, Westefeld M*, Katenka N, Drobyshevsky A, Gorassini M, Quinlan KA*. Frontiers in Cellular Neuroscience, March 2020. 

Optimal mass transport with Lagrangian workflow reveals advective and diffusion driven solute transport in the glymphatic system. Koundal S, Elkin R, Nadeem S, Xue Y, Constantinou S, Sanggaard S, Liu X, Monte B, Xu F*, Van Nostrand WE*, Nedergaard M, Lee H, Wardlaw J, Benveniste H, Tannenbaum A. Scientific Reports, February 2020. PubMed. 

Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques. Zhu X*, Victor T, Ambi A, Sullivan JK*, Hatfield J*, Xu F*, Miller LM, Van Nostrand WE*. Metallomics, February 2020. PubMed.

Developing retinal biomarkers for the earliest stages of Alzheimer’s disease: What we know, what we don’t, and how to move forward. Alber J*, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, Cabrera DeBuc D, Cordeiro F, Provetti‐Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ*. Alzheimer’s Association Journal of Alzheimer’s and Dementia, January 2020. 

Environmental enrichment: disentangling the influence of novelty, social, and physical activity on cerebral amyloid angiopathy in a transgenic mouse model. Robison L, Francis N*, Popescu D, Anderson ME, Hatfield J*, Xu F*, Anderson B, Van Nostrand WE*, Robinson JK*. International Journal of Molecular Science, January 2020. PubMed.

Voluntary wheel running reduces amyloid-β42 and rescues behavior in aged Tg2576 mouse model of Alzheimer’s Disease. Francis N*, Robison LS, Popescu DL, Michaelos M, Hatfield J*, Xu F*, Zhu X*, Davis J*, Anderson ME, Anderson BJ, Van Nostrand WE*, Robinson JK*. Journal of Alzheimers Disease, 2020. PubMed. 

Reduced levels of cerebrospinal fluid/plasma Aβ40 as an early biomarker for cerebral amyloid angiopathy in RTg-DI rats. Zhu X*, Xu F*, Hoos MD, Lee H, Benveniste H, and Van Nostrand WE*. International Journal of Molecular Science, 2020. MDPI.



Anti-neuroinflammatory effects of a food-grade phenolic-enriched maple syrup extract in a mouse model of Alzheimer’s disease. Rose KN*, Barlock BJ, DaSilva NA, Johnson SL*, Liu C, Ma H*, Nelson R*, Akhlaghi F, Seeram NP*. Nutritional Neuroscience, October 2019. Taylor & Francis. PubMed.

Animal models of developmental motor disorders: parallels to human motor dysfunction in cerebral palsy. Cavarsan CF*, Gorassini MA, Quinlan KA*. Journal of Neurophysiology, September 2019. PubMed.

Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy. Robison SL, Popescu DL*, Anderson ME, Francis N, Hatfield J, Sullivan JK, Beigelman SI, Xu F*, Anderson BJ, Van Nostrand WE*, Robinson JK*. Journal of Neuroinflammation, July 2019. PubMed.

Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy. Quinlan KA*, Reedich E, Arnold WD, Puritz A, Cavarsan CF*, Heckman CJ, DiDonato CJ. Journal of Neurophysiology, July 2019. PubMed.

Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling. Chen CD, Zeldich E, Khodr C, Camara K, Tung TY, Lauder EC, Mullen P, Polanco TJ, Liu Y-Y, Zeldich D, Xia W, Van Nostrand WE*, Brown LE, Porco JA, Abrahama CR. Journal of Alzheimer’s Disease, July 2019. PubMed.

Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease Model. Merlini M, Rafalski VA, Rios Coronodo PE, Gill TM, Ellisman M, Muthukumar G, Subramanian KS, Syme CA, Davalos D, Seeley WW, Mucke L, Nelson RB*, Akassoglou K. Neuron, March 2019. PubMed.